Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Helen Torley > Profile

Helen Torley

Affiliations

  • President and Ceo at Halozyme Therapeutics Inc. (HALO), 2026-10-08
  • Director at Quest Diagnostics Inc (DGX), 2021-05-25
  • Director at Relypsa Inc (RLYP), 2016-09-02
  • Evp, Chief Commercial Officer at Onyx Pharmaceuticals Inc (ONXX), 2013-10-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
HALO $8.92 50,000 $446,000.00 50,000 2014-09-16 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
HALO $110.51 200 $22,102.00 767,780 2026-10-08 Filing
HALO $110.00 11,900 $1,308,940.50 767,980 2026-10-08 Filing
HALO $108.91 3,090 $336,525.72 779,880 2026-10-08 Filing
HALO $108.18 4,810 $520,340.99 782,970 2026-10-08 Filing
HALO $113.69 200 $22,738.60 767,780 2026-10-07 Filing